The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy: ECOG-ACRIN EA1211/DIRECT trial.
 
Maeve Hennessy
Employment - Abbvie (I)
Stock and Other Ownership Interests - Abbvie (I)
Travel, Accommodations, Expenses - AstraZeneca; MSD; Roche
 
Constantine Gatsonis
No Relationships to Disclose
 
Heather Jacene
Honoraria - Blue Earth Diagnostics; Munrol
Consulting or Advisory Role - Advanced Accelerator Applications; spectrum dynamics
Research Funding - Blue Earth Diagnostics (Inst); GTx (Inst); Siemens Healthineers (Inst)
Travel, Accommodations, Expenses - GE Healthcare
 
Roisin M. Connolly
Consulting or Advisory Role - Astra Zeneca/Daichii; AstraZeneca; Gilead Sciences
Research Funding - AstraZeneca (Inst); Daichii Sankyo (Inst); MSD (Inst); Pfizer (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis Ireland Ltd.
Other Relationship - Roche
(OPTIONAL) Uncompensated Relationships - AICRI; Astra Zeneca/Daichii (HER2 low obs study); Decrescendo; Develop Med; Seagen
 
Brian Leslie Burnette
No Relationships to Disclose
 
Erica Michelle Stringer-Reasor
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Lilly; Merck; Merck; Novartis; Pumas-AI; Pumas-AI; Seagen
Research Funding - Susan G. Komen for the Cure; V Foundation
 
Justin Romanoff
No Relationships to Disclose
 
Alexander Taurone
No Relationships to Disclose
 
Ciara Catherine O'Sullivan
Honoraria - AstraZeneca (Inst); Medscape (Inst); Seagen (Inst); Seagen (Inst)
Research Funding - Academic & Community Cancer Research United (Inst); Bavarian Nordic (Inst); Eisai (Inst); Genentech (Inst); Lilly (Inst); nference (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - nFerence Astra Zeneca (Inst)
 
Huong T. Le-Petross
No Relationships to Disclose
 
Courtney Lawhn Heath
No Relationships to Disclose
 
Vered Stearns
Consulting or Advisory Role - Novartis
Research Funding - Abbvie (Inst); Biocept (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); QUE Oncology (Inst)
Other Relationship - AstraZeneca
(OPTIONAL) Uncompensated Relationships - Foundation Medicine (Inst)
 
Amy M. Fowler
Consulting or Advisory Role - GE Healthcare
Patents, Royalties, Other Intellectual Property - Elsevier
 
Shou-Ching Tang
No Relationships to Disclose
 
Karla Sepulveda
No Relationships to Disclose
 
Angela DeMichele
Consulting or Advisory Role - Pfizer (I)
Research Funding - Genentech (Inst); Inivata/NeoGenomics (Inst); Novartis (Inst); Pfizer (Inst)
 
David A. Mankoff
Employment - Trevarx Biomedical (I)
Stock and Other Ownership Interests - ImaginAb; Reflexion Medical; Trevarx Biomedical
Consulting or Advisory Role - GE Healthcare; Philips Healthcare
Patents, Royalties, Other Intellectual Property - Trevarx has license to radiopharmaceuticals (I)
Other Relationship - ImaginAb; Reflexion Medical; Trevarx Biomedical
 
Antonio C. Wolff
Patents, Royalties, Other Intellectual Property - Antonio Wolff has been named as inventor on one or more issued patents or pending patent applications relating to methylation in breast cancer, and has assigned his rights to JHU, and participates in a royalty sharing agreement with JHU.